HELSINKI, Finland, Dec. 05, 2024 (GLOBE NEWSWIRE) -- TILT Biotherapeutics (TILT), a clinical-stage biotechnology company developing intravenously delivered cancer immunotherapies, announces it will be ...
Pancreatic cancer usually metastasizes to the liver and peritoneum ... recipients; and (3) SYN-020, a recombinant oral formulation of the enzyme intestinal alkaline phosphatase (IAP) produced under ...
Discover how OraLiva, a groundbreaking oral cancer screening device and diagnostic platform, is bridging the gap in the market and revolutionizing early detection.